VEGFA and Alzheimer disease: If this were determined to be true, then inhibiting VEGF-A signaling via an IgG antibody could prove to be beneficial in AD patients as this inhibition would decrease capillary stalling but would have no effect on the positive aspects of VEGF-A signaling.